Updated on: Dec 20, 2025 01:42 am IST
President Trump has launched TrumpRx.gov to reduce prescription drug costs, claiming price cuts of 400% to 600% by January 2026.Â
President Donald Trump has announced a new initiative aimed at lowering prescription drug costs, unveiling TrumpRx.gov, a website he says will offer Americans access to sharply reduced drug prices beginning in January 2026.
The announcement came during a White House press conference, where Trump said he had negotiated directly with pharmaceutical companies and foreign governments to secure dramatic price reductions. âIâm doing what no politician of either party has ever doneâstanding up to the special interests to dramatically reduce the price of prescription drugs,â Trump said.
What is TrumpRx.gov?
TrumpRx.gov is described by the president as a central portal where Americans will be able to purchase or access prescription medications at significantly lower prices.
While the site is not yet operational, it currently displays the message: âComing soon. January 2026â
Also Read: Trump drug price announcement: List of 9 companies under new sweep of Most Favored Nation program
Trump said the first wave of drug price cuts would be rolled out through the platform, with reductions ranging from 400% to 600%.
How would it lower drug prices?
Trump argues that his plan bypasses what he calls inflated pricing structures maintained by insurers and middlemen. In his remarks, he accused health insurance companies of âgetting rich on billions of dollars of money that should go directly to the people.â
He also criticized the Affordable Care Act (ACA), calling it âunaffordableâ and claiming it was designed to benefit insurance companies.
Read More: Fact checking Trump’s claims from primetime speech: What to know about gas prices, electricity bills, egg cost and more
The announcement comes as millions of Americans who rely on ACA marketplace plans face sharp premium increases next year, PBS NewsHour reported. According to the report, average premiums are expected to roughly double after Congress failed to reach an agreement on extending enhanced subsidies set to expire at the end of the month.
